Promising response to vemurafenib and cobimetinib treatment for BRAF V600E mutated craniopharyngioma: a case report and literature review

Reference

• Hung ND, Ngan VK, Duc NM. Intrinsic third ventricular papillary craniopharyngioma: a report of five cases and literature review. Int Med Case Rep J 14, 83–87 (2021).
   PubMed Web of Science ®Google Scholar
• Behari S, Banerji D, Mishra A et al. Intrinsic third ventricular craniopharyngiomas: report on six cases and a review of the literature. Surg. Neurol. 60(3), 245–252; discussion 252–243 (2003).
   PubMedGoogle Scholar
• Müller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S. Craniopharyngioma. Nat Rev Dis Primers 5(1), 75 (2019).
   PubMed Web of Science ®Google Scholar
• Goschzik T, Gessi M, Dreschmann V et al. Genomic alterations of adamantinomatous and papillary craniopharyngioma. J. Neuropathol. Exp. Neurol. 76(2), 126–134 (2017).
   PubMed Web of Science ®Google Scholar
• Pascual JM, González-Llanos F, Barrios L, Roda JM. Intraventricular craniopharyngiomas: topographical classification and surgical approach selection based on an extensive overview. Acta Neurochir (Wien) 146(8), 785–802 (2004).
   PubMed Web of Science ®Google Scholar
• Tayari N, Etemadifar M, Hekmatnia A, Mahzouni P, Maghzi AH, Rouzbahani R. Intrinsic third ventricular craniopharyngioma: a case report. Int J Prev Med 2(3), 178–185 (2011).
   PubMedGoogle Scholar
• Prieto R, Pascual JM, Barrios L. Topographic diagnosis of craniopharyngiomas: the accuracy of MRI findings observed on conventional T1 and T2 images. AJNR Am. J. Neuroradiol. 38(11), 2073–2080 (2017).
   PubMed Web of Science ®Google Scholar
• Maira G, Anile C, Colosimo C, Cabezas D. Craniopharyngiomas of the third ventricle: trans-lamina terminalis approach. Neurosurgery 47(4), 857–863; discussion 863–855 (2000).
   PubMed Web of Science ®Google Scholar
• Iwasaki K, Kondo A, Takahashi JB, Yamanobe K. Intraventricular craniopharyngioma: report of two cases and review of the literature. Surg. Neurol. 38(4), 294–301 (1992).
   PubMedGoogle Scholar
• Komotar RJ, Roguski M, Bruce JN. Surgical management of craniopharyngiomas. J. Neurooncol. 92(3), 283–296 (2009).
   PubMed Web of Science ®Google Scholar
• Jung TY, Jung S, Jang WY, Moon KS, Kim IY, Kang SS. Operative outcomes and adjuvant treatment of purely third ventricle craniopharyngioma after a transcallosal approach. Br. J. Neurosurg. 26(3), 355–360 (2012).
   PubMed Web of Science ®Google Scholar
• Ikezaki K, Fujii K, Kishikawa T. Magnetic resonance imaging of an intraventricular craniopharyngioma. Neuroradiology 32(3), 247–249 (1990).
   PubMed Web of Science ®Google Scholar
• Bülow B, Attewell R, Hagmar L, Malmström P, Nordström CH, Erfurth EM. Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence. J. Clin. Endocrinol. Metab. 83(11), 3897–3904 (1998).
   PubMed Web of Science ®Google Scholar
• Tolnay M, Kaim A, Probst A, Ulrich J. Subependymoma of the third ventricle after partial resection of a craniopharyngioma and repeated postoperative irradiation. Clin. Neuropathol. 15(2), 63–66 (1996).
   PubMed Web of Science ®Google Scholar
• Sagoh M, Murakami H, Hirose Y, Mayanagi K. Occlusive cerebrovasculopathy after internal radiation and bleomycin therapy for craniopharyngioma--case report. Neurol Med Chir (Tokyo) 37(12), 920–923 (1997).
   PubMedGoogle Scholar
• Brastianos PK, Taylor-Weiner A, Manley PE et al. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat. Genet. 46(2), 161–165 (2014).
   PubMed Web of Science ®Google Scholar
• Long GV, Eroglu Z, Infante J et al. Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma who received dabrafenib combined with trametinib. J. Clin. Oncol. 36(7), 667–673 (2018).
   PubMed Web of Science ®Google Scholar
• Brastianos PK, Shankar GM, Gill CM et al. Dramatic response of BRAF V600E mutant papillary craniopharyngioma to targeted therapy. J. Natl Cancer Inst. 108(2), djv310 (2016).
   PubMedGoogle Scholar
• Nussbaum PE, Nussbaum LA, Torok CM, Patel PD, Yesavage TA, Nussbaum ES. Case report and literature review of BRAF-V600 inhibitors for treatment of papillary craniopharyngiomas: a potential treatment paradigm shift. J. Clin. Pharm. Ther. 47(6), 826–831 (2022).
   PubMed Web of Science ®Google Scholar
• Juratli TA, Jones PS, Wang N et al. Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations. Cancer 125(17), 2910–2914 (2019).
   PubMed Web of Science ®Google Scholar
• Bernstein A, Mrowczynski OD, Greene A et al. Dual BRAF/MEK therapy in BRAF V600E-mutated primary brain tumors: a case series showing dramatic clinical and radiographic responses and a reduction in cutaneous toxicity. J. Neurosurg. doi:10.3171/2019.8.Jns19643, 1–6 (2019).
   Web of Science ®Google Scholar
• Rostami E, Witt Nyström P, Libard S, Wikström J, Casar-Borota O, Gudjonsson O. Recurrent papillary craniopharyngioma with BRAFV600E mutation treated with neoadjuvant-targeted therapy. Acta Neurochir (Wien) 159(11), 2217–2221 (2017).
   PubMed Web of Science ®Google Scholar
• Roque A, Odia Y. BRAF-V600E mutant papillary craniopharyngioma dramatically responds to combination BRAF and MEK inhibitors. CNS Oncol 6(2), 95–99 (2017).
   PubMedGoogle Scholar
• Di Stefano AL, Guyon D, Sejean K et al. Medical debulking with BRAF/MEK inhibitors in aggressive BRAF-mutant craniopharyngioma. Neurooncol Adv 2(1), vdaa141 (2020).
   PubMedGoogle Scholar
• Aylwin SJ, Bodi I, Beaney R. Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor. Pituitary 19(5), 544–546 (2016).
   PubMed Web of Science ®Google Scholar
• Rao M, Bhattacharjee M, Shepard S, Hsu S. Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report. Oncotarget 10(57), 6038–6042 (2019).
   PubMedGoogle Scholar
• Himes BT, Ruff MW, Van Gompel JJ et al. Recurrent papillary craniopharyngioma with BRAF V600E mutation treated with dabrafenib: case report. J. Neurosurg. doi:10.3171/2017.11.Jns172373, 1–5 (2018).
   Web of Science ®Google Scholar